SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-219537
Filing Date
2013-05-14
Accepted
2013-05-14 16:10:32
Documents
3
Period of Report
2013-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d538918d8k.htm 8-K 16429
2 EX-99.1 d538918dex991.htm EX-99.1 49842
3 GRAPHIC g538918logo.jpg GRAPHIC 17637
  Complete submission text file 0001193125-13-219537.txt   91860
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 13841657
SIC: 2834 Pharmaceutical Preparations